TCL Archive NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending July 12, 2013
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation February 19, 2010
TCL Archive Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting December 11, 1987
